Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-21

Clinical Trial Update: Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a fludarabine and total body irradiation regimen as conditioning for allogeneic hematopoietic cell transplantation in adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludarabine / Total Body Irradiation regimen

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Adult Lymphoblastic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-21